Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1991 1
1992 1
1996 1
2000 1
2014 1
2015 3
2016 3
2017 10
2018 12
2019 6
2020 14
2021 17
2022 11
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Clonal evolution during metastatic spread in high-risk neuroblastoma.
Gundem G, Levine MF, Roberts SS, Cheung IY, Medina-Martínez JS, Feng Y, Arango-Ossa JE, Chadoutaud L, Rita M, Asimomitis G, Zhou J, You D, Bouvier N, Spitzer B, Solit DB, Dela Cruz F, LaQuaglia MP, Kushner BH, Modak S, Shukla N, Iacobuzio-Donahue CA, Kung AL, Cheung NV, Papaemmanuil E. Gundem G, et al. Among authors: cheung nv. Nat Genet. 2023 Jun;55(6):1022-1033. doi: 10.1038/s41588-023-01395-x. Epub 2023 May 11. Nat Genet. 2023. PMID: 37169874
Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells.
Li S, Liu M, Do MH, Chou C, Stamatiades EG, Nixon BG, Shi W, Zhang X, Li P, Gao S, Capistrano KJ, Xu H, Cheung NV, Li MO. Li S, et al. Among authors: cheung nv. Nature. 2020 Nov;587(7832):121-125. doi: 10.1038/s41586-020-2850-3. Epub 2020 Oct 21. Nature. 2020. PMID: 33087933 Free PMC article.
Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.
Chung SK, Vargas DB, Chandler CS, Katugampola S, Veach DR, McDevitt MR, Seo SH, Vaughn BA, Rinne SS, Punzalan B, Patel M, Xu H, Guo HF, Zanzonico PB, Monette S, Yang G, Ouerfelli O, Nash GM, Cercek A, Fung EK, Howell RW, Larson SM, Cheal SM, Cheung NV. Chung SK, et al. Among authors: cheung nv. J Nucl Med. 2023 Sep;64(9):1439-1445. doi: 10.2967/jnumed.122.265095. Epub 2023 Jun 22. J Nucl Med. 2023. PMID: 37348919 Free PMC article.
Bispecific antibodies for the treatment of neuroblastoma.
Espinosa-Cotton M, Cheung NV. Espinosa-Cotton M, et al. Among authors: cheung nv. Pharmacol Ther. 2022 Sep;237:108241. doi: 10.1016/j.pharmthera.2022.108241. Epub 2022 Jul 10. Pharmacol Ther. 2022. PMID: 35830901 Free PMC article. Review.
Pretargeting: A Path Forward for Radioimmunotherapy.
Cheal SM, Chung SK, Vaughn BA, Cheung NV, Larson SM. Cheal SM, et al. Among authors: cheung nv. J Nucl Med. 2022 Sep;63(9):1302-1315. doi: 10.2967/jnumed.121.262186. J Nucl Med. 2022. PMID: 36215514 Free article. Review.
Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy.
Santich BH, Cheung NV, Klein C. Santich BH, et al. Among authors: cheung nv. Front Oncol. 2020 Dec 9;10:628005. doi: 10.3389/fonc.2020.628005. eCollection 2020. Front Oncol. 2020. PMID: 33363043 Free PMC article. No abstract available.
Stage 4N neuroblastoma before and during the era of anti-GD2 immunotherapy.
Kushner BH, LaQuaglia MP, Cardenas FI, Basu EM, Gerstle JT, Kramer K, Roberts SS, Wolden SL, Cheung NV, Modak S. Kushner BH, et al. Among authors: cheung nv. Int J Cancer. 2023 Dec 15;153(12):2019-2031. doi: 10.1002/ijc.34693. Epub 2023 Aug 21. Int J Cancer. 2023. PMID: 37602920
85 results